Related Experiment Videos
Can high resolution computed tomography predict lung function in patients with chronic obstructive pulmonary disease?
K Spiropoulos1, G Trakada, D Kalamboka
1Division of Pulmonology, Laboratory of Cardiopulmonary Exercise Test, Patras, Greece. gtrakpmd@med.upatras.gr
Lung
|December 25, 2003
Summary
High-resolution computed tomography (HRCT) effectively quantifies emphysema severity in chronic obstructive pulmonary disease (COPD). HRCT findings, particularly in the middle lung regions during expiration, correlate significantly with various pulmonary function tests, aiding COPD assessment.
Area of Science:
- Pulmonary Medicine
- Radiology
- Medical Imaging
Background:
- Chronic obstructive pulmonary disease (COPD) diagnosis requires airflow limitation, emphysema, and/or chronic bronchitis.
- High-resolution computed tomography (HRCT) is valuable for quantifying emphysema extent.
- Limited studies explore HRCT-pulmonary function test (PFT) relationships in COPD.
Purpose of the Study:
- To investigate the correlation between HRCT imaging and PFTs in patients with moderate COPD.
- To assess HRCT's utility in evaluating COPD severity.
Main Methods:
- Twenty former smokers with moderate COPD underwent spirometry, body plethysmography, and exercise testing.
- HRCT scans were obtained at full inspiration and expiration at three lung levels.
- Correlations between HRCT grades and PFT parameters were analyzed.
Main Results:
- Pulmonary function parameters significantly correlated with HRCT grades in the middle lung regions during expiration.
- Forced expiratory volume in 1 second (FEV1) showed significant correlations with HRCT across multiple lung regions and phases.
- HRCT findings, especially in the middle right and left lungs during expiration, demonstrated strong correlations with key PFTs.
Conclusions:
- HRCT is a valuable tool for assessing COPD severity.
- HRCT, particularly during expiration in middle lung zones, correlates well with PFTs.
- HRCT can aid in the comprehensive evaluation of COPD patients.